Home | Health News | Themes | Search | Blog | Testimonials | Blood Bank | About Us
 
   
   
   
   
   
   
   
 
testing

 
   
 



Indication & Dosage
 
 
Intravenous
VARICEAL HAEMORRHAGE IN PATIENTS WITH CIRRHOSIS
Adult: As continuous IV infusion: 25 mcg/hr for 48 hr (up to 5 days in patients at high risk of re-bleeding).
 
Intravenous
VARICEAL HAEMORRHAGE IN PATIENTS WITH CIRRHOSIS
Child: ≥1 mth: 1 mcg/kg/hr (up to 50 mcg/hr); given as continuous IV infusion. Higher doses may be needed initially, reduce dose gradually over 24 hr until bleeding has stopped.
 
Intramuscular
ACROMEGALY
Adult:  Following initial control with SC therapy: As a depot preparation, initially 20 mg every 4 wk. Adjust if required after 3 mth to 10-30 mg every 4 wk.
 
Subcutaneous
ACROMEGALY
Adult:  Initially 50 mcg tid, increased as necessary to usual dose 100-200 mcg tid. Max: 500 mcg tid
Max Dosage:   40 mg every 4 wk.
 
Subcutaneous
PREVENTION OF COMPLICATIONS FOLLOWING PANCREATIC SURGERY
Adult: 100 mcg tid of a rapid-acting preparation given for 7 consecutive days, starting at least 1 hr before operation.
 
Subcutaneous
HIV ASSOCIATED DIARRHOEA
Adult:  Initial dose 100 mcg tid. If symptoms are not controlled after 1 wk, increase dose to 250 mcg tid, if still not effective after 1 wk stop therapy.
 
Parenteral
SECRETORY NEOPLASMS
Adult: As SC inj: Initially, 50 mcg 1-2 times daily, increased gradually to up to 600 mcg daily in 2-4 divided doses according to response. Usually given SC but IV inj may be used where a rapid response is required and an IM depot inj of 10-30 mg every 4 wk can be used as maintenance therapy.
   
Precautions Renal disease; risk of gall bladder disease; DM; hypothyroidism. Pregnancy, lactation, children, elderly. Monitor levels of vitamin B12 during long term therapy.
   
Adverse Drug Reactions Local pain, stinging, tingling at site of inj; anorexia, nausea, vomiting, abdominal pain, bloating, flatulence, loose stools, steatorrhoea; biliary tract abnormalities. Hypoglycaemia and hyperglycaemia, hypothyroidism, cardiac conduction abnormalitles, pancreatitis.
   
Interactions

Dosage adjustment of concurrent therapy may be necessary with calcium channel blockers, oral hypoglycaemics, β-blockers, diuretics. May increase concentration of bromocriptine.

   
   
 

 

SocialTwist Tell-a-Friend
 
 
Home  |   Privacy Policy   |   News Lettter   |   Site Map   |  Disclaimer  |  About Us
   copyright@totalhealthneeds.com   Webmaster:- o3sa.co.in